| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 10/12/2023 | 15.22% | Barclays | $55 → $47 | Maintains | Equal-Weight |
| 07/27/2023 | 20.13% | RBC Capital | $42 → $49 | Maintains | Sector Perform |
| 07/27/2023 | 37.29% | Credit Suisse | $47 → $56 | Maintains | Outperform |
| 07/27/2023 | 34.84% | Barclays | $52 → $55 | Maintains | Equal-Weight |
| 07/26/2023 | 49.55% | Wedbush | → $61 | Reiterates | Outperform → Outperform |
| 06/28/2023 | 49.55% | Wedbush | $45 → $61 | Maintains | Outperform |
| 06/14/2023 | — | Seaport Global | Initiates Coverage On | → Neutral | |
| 06/01/2023 | 22.58% | Deutsche Bank | → $50 | Initiates Coverage On | → Hold |
| 05/24/2023 | 27.48% | Barclays | $45 → $52 | Maintains | Equal-Weight |
| 04/27/2023 | 2.97% | RBC Capital | $33 → $42 | Maintains | Sector Perform |
| 04/27/2023 | 15.22% | Credit Suisse | $41 → $47 | Maintains | Outperform |
| 04/27/2023 | 10.32% | Barclays | $40 → $45 | Maintains | Equal-Weight |
| 02/16/2023 | -1.94% | Barclays | $35 → $40 | Maintains | Equal-Weight |
| 02/16/2023 | 0.51% | Credit Suisse | $33 → $41 | Maintains | Outperform |
| 10/27/2022 | — | BTIG | Downgrades | Buy → Neutral | |
| 10/18/2022 | -36.26% | B. Riley Securities | $28 → $26 | Maintains | Neutral |
| 07/28/2022 | -26.45% | Wells Fargo | $25 → $30 | Maintains | Equal-Weight |
| 07/28/2022 | -28.9% | RBC Capital | $28 → $29 | Downgrades | Outperform → Sector Perform |
| 07/12/2022 | -26.45% | JP Morgan | $35 → $30 | Maintains | Overweight |
| 07/11/2022 | -19.1% | Credit Suisse | → $33 | Upgrades | Neutral → Outperform |
| 06/22/2022 | -31.36% | RBC Capital | $32 → $28 | Upgrades | Sector Perform → Outperform |
| 06/17/2022 | -38.71% | Wells Fargo | $28 → $25 | Maintains | Equal-Weight |
| 06/16/2022 | -31.36% | B. Riley Securities | $36 → $28 | Downgrades | Buy → Neutral |
| 04/13/2022 | -26.45% | JP Morgan | $40 → $30 | Maintains | Overweight |
| 04/06/2022 | -11.74% | B. Riley Securities | $45 → $36 | Maintains | Buy |
| 04/05/2022 | -21.55% | Credit Suisse | → $32 | Initiates Coverage On | → Neutral |
| 03/31/2022 | -19.1% | Barclays | $41 → $33 | Downgrades | Overweight → Equal-Weight |
| 03/10/2022 | -1.94% | JP Morgan | $49.5 → $40 | Maintains | Overweight |
| 12/15/2021 | 10.32% | Barclays | $42 → $45 | Maintains | Overweight |
| 10/28/2021 | 2.97% | Barclays | $40 → $42 | Maintains | Overweight |
| 10/28/2021 | -16.65% | RBC Capital | $32 → $34 | Maintains | Sector Perform |
| 04/16/2021 | -16.65% | Wells Fargo | → $34 | Initiates Coverage On | → Equal-Weight |
| 03/16/2021 | — | Wolfe Research | Initiates Coverage On | → Peer Perform | |
| 02/22/2021 | — | Keybanc | Initiates Coverage On | → Sector Weight | |
| 01/22/2021 | -26.45% | Janney Capital | → $30 | Initiates Coverage On | → Neutral |
| 01/08/2021 | -33.81% | RBC Capital | $31 → $27 | Downgrades | Outperform → Sector Perform |
| 10/16/2020 | -21.55% | BTIG | $28 → $32 | Maintains | Buy |
| 07/21/2020 | -26.45% | BTIG | → $30 | Upgrades | Neutral → Buy |
| 07/09/2020 | -38.71% | B. Riley Securities | $19 → $25 | Maintains | Buy |
| 06/11/2020 | -33.81% | JP Morgan | → $27 | Upgrades | Neutral → Overweight |
| 05/12/2020 | -60.77% | Wells Fargo | $14 → $16 | Maintains | Equal-Weight |
| 05/07/2020 | -53.42% | B. Riley Securities | $23 → $19 | Maintains | Buy |
| 03/18/2020 | -75.48% | JP Morgan | → $10 | Downgrades | Overweight → Neutral |
| 03/17/2020 | -43.61% | B. Riley Securities | $33 → $23 | Maintains | Buy |
| 08/01/2019 | -41.16% | Wells Fargo | $21 → $24 | Maintains | Market Perform |
| 08/01/2019 | -36.26% | B. Riley Securities | $22 → $26 | Upgrades | Neutral → Buy |
| 07/19/2019 | -43.61% | Barclays | $20 → $23 | Maintains | Equal-Weight |
| 05/16/2019 | — | RBC Capital | Upgrades | Sector Perform → Outperform | |
| 05/13/2019 | -41.16% | Wedbush | $22 → $24 | Upgrades | Neutral → Outperform |
| 05/13/2019 | -50.97% | Barclays | $19 → $20 | Upgrades | Underweight → Equal-Weight |
| 05/02/2019 | -38.71% | Citigroup | $22 → $25 | Maintains | Buy |
| 03/07/2019 | — | JP Morgan | Upgrades | Neutral → Overweight | |
| 02/14/2019 | -48.52% | B. Riley Securities | $20 → $21 | Maintains | Neutral |
| 01/14/2019 | -47.29% | Wells Fargo | → $21.5 | Downgrades | Outperform → Market Perform |
| 11/02/2018 | -41.16% | Wells Fargo | $33.5 → $24 | Maintains | Outperform |
| 11/01/2018 | -60.77% | Deutsche Bank | $14 → $16 | Maintains | Hold |
| 10/29/2018 | -53.42% | Citigroup | $27 → $19 | Maintains | Buy |
| 10/29/2018 | -53.42% | Citigroup | → $19 | Reinstates | → Buy |
| 10/22/2018 | -65.68% | Deutsche Bank | $25 → $14 | Downgrades | Buy → Hold |
What is the target price for Taylor Morrison Home (TMHC)?
The latest price target for Taylor Morrison Home (NYSE: TMHC) was reported by Barclays on October 12, 2023. The analyst firm set a price target for $47.00 expecting TMHC to rise to within 12 months (a possible 15.22% upside). 16 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Taylor Morrison Home (TMHC)?
The latest analyst rating for Taylor Morrison Home (NYSE: TMHC) was provided by Barclays, and Taylor Morrison Home maintained their equal-weight rating.
When is the next analyst rating going to be posted or updated for Taylor Morrison Home (TMHC)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Taylor Morrison Home, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Taylor Morrison Home was filed on October 12, 2023 so you should expect the next rating to be made available sometime around October 12, 2024.
Is the Analyst Rating Taylor Morrison Home (TMHC) correct?
While ratings are subjective and will change, the latest Taylor Morrison Home (TMHC) rating was a maintained with a price target of $55.00 to $47.00. The current price Taylor Morrison Home (TMHC) is trading at is $40.79, which is out of the analyst's predicted range.